Carregant...

Investigation of ovarian cancer associated sialylation changes in N-linked glycopeptides by quantitative proteomics

BACKGROUND: In approximately 80% of patients, ovarian cancer is diagnosed when the patient is already in the advanced stages of the disease. CA125 is currently used as the marker for ovarian cancer; however, it lacks specificity and sensitivity for detecting early stage disease. There is a critical...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shetty, Vivekananda, Hafner, Julie, Shah, Punit, Nickens, Zacharie, Philip, Ramila
Format: Artigo
Idioma:Inglês
Publicat: Springer 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3488482/
https://ncbi.nlm.nih.gov/pubmed/22856521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1559-0275-9-10
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!